IMC Chicago
PRCT icon

IMC Chicago’s Procept Biorobotics PRCT Stock Holding History

IMC Chicago’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
59,400
+20,300
+52% +$508K ﹤0.01% 3493
2026
Q1 		$978K Buy
39,100
+16,700
+75% +$471K ﹤0.01% 3311
2025
Q4 		$705K Buy
22,400
+500
+2% +$16.6K ﹤0.01% 3247
2025
Q3 		$782K Buy
21,900
+5,500
+34% +$251K ﹤0.01% 2887
2025
Q2 		$945K Buy
+16,400
New +$927K ﹤0.01% 2527
2025
Q1 		– Sell
-15,400
Closed -$1.24M – 3400
2024
Q4 		$1.24M Buy
+15,400
New +$1.32M ﹤0.01% 2213

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

IMC Chicago's PRCT Position: Q2 2026 in Review

IMC Chicago increased its Procept Biorobotics (PRCT) stake by 23% in Q2 2026, buying an estimated $115K and bringing the position to 24,495 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #4528.

IMC Chicago first reported a position in PRCT in Q4 2025 and has held it in 3 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • IMC Chicago held 24,495 shares of Procept Biorobotics worth $553K as of Q2 2026.
  • IMC Chicago bought 4,598 Procept Biorobotics shares in Q2 2026, an estimated $115K.
  • Procept Biorobotics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4528 holding.
  • IMC Chicago first reported a position in Procept Biorobotics in Q4 2025 and has held it in 3 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.